Short interest in NeuroBo Pharmaceuticals Inc (NASDAQ:NRBO) decreased during the last reporting period, falling from 43.63K to 28.12K. This put 0.91% of the company's publicly available shares short.

Short interest for NeuroBo Pharmaceuticals gives investors a sense of the degree to which investors are betting on the decline of NeuroBo Pharmaceuticals's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 20.58K shares traded per day, it would take 1.37 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.